Medical and Scientific: Drug hope for blood cancer

15 Feb 2021 - Medical and Scientific

One hundred cancer sufferers are involved in a world first $2m Adelaide-based trial of next-generation drugs to treat chronic myeloid leukaemia (CML). Researchers are conducting the first frontline clinical study that is set to revolutionise the treatment of CML. South Australian CML patients were among those in the trial to have received initial doses of the drug, asciminib, 30 days ago. “There is no other patient in the world that has access to this frontline therapy,” the study’s co-lead researcher, Professor Tim Hughes, said. “I think it has the potential to be a game-changer in the way we treat CML around the world.”

Sunday Mail Adelaide; 14/02/2021; Page 21